📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ZS Pharma

1.1 - Company Overview

ZS Pharma Logo

ZS Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of highly selective ion-trap therapies and therapeutic candidates to treat serious, life-threatening conditions, including hyperkalemia and liver diseases; a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA, focused on R&D, with ZS-9 as a novel treatment candidate for hyperkalemia.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ZS Pharma

Lewis and Clark Pharmaceuticals Logo

Lewis and Clark Pharmaceuticals

HQ: United States Website
  • Description: Provider of early-stage pharmaceutical development targeting treatments for arthritis, diabetes, glaucoma, and atherosclerosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lewis and Clark Pharmaceuticals company profile →
Pearl Therapeutics Logo

Pearl Therapeutics

HQ: United States Website
  • Description: Provider of unique dual and triple combination inhaled therapies for widely prevalent respiratory diseases, including chronic obstructive pulmonary disease, delivered via familiar metered dose inhalers to broaden patient access.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pearl Therapeutics company profile →
InMed Pharmaceuticals Logo

InMed Pharmaceuticals

HQ: Canada Website
  • Description: Provider of cannabinoid-based pharmaceutical candidates and rare cannabinoid ingredients. Develops INM-755 (cannabinol topical for epidermolysis bullosa) and INM-088 (cannabinol-based for glaucoma). Through BayMedica, supplies bioidentical rare cannabinoids (CBC, d9-THCV, CBDV, CBTC) for B2B health and wellness. Offers IntegraSyn, combining biosynthesis and chemical synthesis to produce cannabinoids, aiming for high yield and cost efficiency.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full InMed Pharmaceuticals company profile →
Merck Logo

Merck

HQ: Germany Website
  • Description: Provider of life science, healthcare, and electronics solutions in the U.S. and Canada as EMD Serono, MilliporeSigma, and EMD Electronics. Supplies lab chemicals, solvents, materials, and tools; process solutions for drug development; end-to-end testing, analytics, and manufacturing support; develops medicines and devices for cancer, multiple sclerosis, fertility, and endocrine disorders; and materials/equipment for semiconductors, displays, and surfaces.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Merck company profile →
Arena Pharmaceuticals Logo

Arena Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical research and development focused on cardiovascular, central nervous system, inflammatory, and metabolic diseases, including the development of lorcaserin hydrochloride, which has reported positive clinical trial data. Headquartered in San Diego, CA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arena Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ZS Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ZS Pharma

2.2 - Growth funds investing in similar companies to ZS Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ZS Pharma

4.2 - Public trading comparable groups for ZS Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ZS Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ZS Pharma

What does ZS Pharma do?

ZS Pharma is a provider of highly selective ion-trap therapies and therapeutic candidates to treat serious, life-threatening conditions, including hyperkalemia and liver diseases; a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA, focused on R&D, with ZS-9 as a novel treatment candidate for hyperkalemia.

Who are ZS Pharma's competitors?

ZS Pharma's competitors and similar companies include Lewis and Clark Pharmaceuticals, Pearl Therapeutics, InMed Pharmaceuticals, Merck, and Arena Pharmaceuticals.

Where is ZS Pharma headquartered?

ZS Pharma is headquartered in United States.

How many employees does ZS Pharma have?

ZS Pharma has 1,000 employees 🔒.

When was ZS Pharma founded?

ZS Pharma was founded in 2010 🔒.

What sector and industry vertical is ZS Pharma in?

ZS Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ZS Pharma

Who are the top strategic acquirers in ZS Pharma's sector and industry

Top strategic M&A buyers and acquirers in ZS Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ZS Pharma?

Top strategic M&A buyers groups and sectors for ZS Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ZS Pharma's sector and industry vertical

Which are the top PE firms investing in ZS Pharma's sector and industry vertical?

Top PE firms investing in ZS Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ZS Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ZS Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ZS Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ZS Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ZS Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ZS Pharma?

The key public trading comparables and valuation benchmarks for ZS Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ZS Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ZS Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ZS Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ZS Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ZS Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in ZS Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ZS Pharma